Published October 20, 2017 | Version v1
Journal article Open

Anti-tumour necrosis factor activity in saliva of various tick species and its appearance during the feeding period

Description

Rezková, Markéta, Kopecký, Jan (2017): Anti-tumour necrosis factor activity in saliva of various tick species and its appearance during the feeding period. Folia Parasitologica (032) 64: 1-5, DOI: 10.14411/fp.2017.032, URL: http://dx.doi.org/10.14411/fp.2017.032

Files

source.pdf

Files (364.1 kB)

Name Size Download all
md5:3f138553e34baea5875c8805ca4c69da
364.1 kB Preview Download

Linked records

Additional details

Identifiers

LSID
urn:lsid:plazi.org:pub:3F138553E34BFFA5875C8805CA4CFFDA

References

  • BERNARD Q., GALLO R.L., JAULHAC B., NAKATSUJI T., LUFT B., YANG X., BOULANGER N. 2016: Ixodes tick saliva suppresses the keratinocyte cytokine response to TLR2/TLR3 ligands during early exposure to Lyme borreliosis. Exp. Dermatol. 25: 26-31.
  • BONVIN P., POWER C.A., PROUDFOOT A.E. 2016: Evasins: therapeutic potential of a new family of chemokine-binding proteins from ticks. Front. Immunol. 7: 208.
  • BRADLEY J.R. 2008: TNF-mediated inflammatory disease. J. Pathol. 214: 149-160.
  • CUMBERBATCH M., KIMBER I. 1995: Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 84: 31-35.
  • DERUAZ M., FRAUENSCHUH A., ALESSANDRI A.L., DIAS J.M., COELHO F.M., RUSSO R.C., FERREIRA B.R., GRAHAM G.J., SHAW J.P., WELLS T.N., TEIXEIRA M.M., POWER C.A., PROUDFOOT A.E. 2008: Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. J. Exp. Med. 205: 2019-2031.
  • EISEN L., LANE R.S. 2002: Vectors of Borrelia burgdorferi sensu lato. In: J. Gray, O. Kahl, R.S. Lane and G. Stanek (Eds.), Lyme other tick species, but with the inhibitory effect on TNF expression.
  • ESTRADA A., VAN KESSEL A., YUN C.M., LI B. 1998: Effect of endotoxin on cytokine production and cell dynamics in mice. Immunopharmacol. Immunotoxicol. 20: 217-231.
  • FERREIRA B.R., SZABO M.J., CAVASSANI K.A., BECHARA G.H., SILVA J.S. 2003: Antigens from Rhipicephalus sanguineus ticks elicit potent cell-mediated immune responses in resistant but not in susceptible animals. Vet. Parasitol. 115: 35-48.
  • FRANCISCHETTI I.M., SA-NUNES A., MANS B.J., SANTOS I.M., RIBEIRO J.M. 2009: The role of saliva in tick feeding. Front. Biosci. 14: 2051-2088.
  • FUCHSBERGER N., KITA M., HAJNICKA V., IMANISHI J., LABUDA M., NUTTALL P.A. 1995: Ixodid tick salivary gland extracts inhibit production of lipopolysaccharide-induced mRNA of several different human cytokines. Exp. Appl. Acarol. 19: 671-676.
  • GILLESPIE R.D., DOLAN M.C., PIESMAN J., TITUS R.G. 2001: Identification of an IL-2 binding protein in the saliva of the Lyme disease vector tick, Ixodes scapularis. J. Immunol. 166: 4319-4326.
  • GWAKISA P., YOSHIHARA K., LONG TO T., GOTOH H., AMANO F., MOMOTANI E. 2001: Salivary gland extract of Rhipicephalus appendiculatus ticks inhibits in vitro transcription and secretion of cytokines and production of nitric oxide by LPS-stimulated JA-4 cells. Vet. Parasitol. 99: 53-61.
  • HAJNICKA V., VANcOVA I., KOCAKOVA P., SLOVAK M., GASPERIK J., SLAVIKOVA M., HAILS R.S., LABUDA M., NUTTALL P.A. 2005: Manipulation of host cytokine network by ticks: a potential gateway for pathogen transmission. Parasitology 130: 333-342.
  • HEHLGANS T., PFEFFER K. 2005: The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115: 1-20.
  • KERN A., COLLIN E., BARTHEL C., MICHEL C., JAULHAC B., BOULANGER N. 2011: Tick saliva represses innate immunity and cutaneous inflammation in a murine model of Lyme disease. Vector Borne Zoonotic Dis. 11: 1343-1350.
  • KONIK P., SLAVIKOVA V., SALAT J., REZNIcKOVA J., DVOROZNAKOVA E., KOPECKy J. 2006: Anti-tumour necrosis factor-alpha activity in Ixodes ricinus saliva. Parasite Immunol. 28: 649-656.
  • MARCHAL C., SCHRAMM F., KERN A., LUFT B.J., YANG X., SCHUIJT T.J., HOVIUS J.W., JAULHAC B., BOULANGER N. 2011: Antialarmin effect of tick saliva during the transmission of Lyme disease. Infect. Immun. 79: 774-785.
  • MICHELET L., DELANNOY S., DEVILLERS E., UMHANG G., ASPAN A., JUREMALM M., CHIRICO J., VAN DER WAL F.J., SPRONG H., BOYE PIHL T.P., KLITGAARD K., BODKER R., FACH P., MOUTAILLER S. 2014: High-throughput screening of tick-borne pathogens in Europe. Front. Cell. Infect. Microbiol. 4: 103.
  • NAWROTH P.P., STERN D.M. 1986: Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J. Exp. Med. 163: 740-745.
  • PAESEN G.C., ADAMS P.L., HARLOS K., NUTTALL P.A., STUART D.I. 1999: Tick histamine-binding proteins: isolation, cloning, and three-dimensional structure. Mol. Cell 3: 661-671.
  • PEETRE C., THYSELL H., GRUBB A., OLSSON I. 1988: A tumor necrosis factor binding protein is present in human biological fluids. Eur. J. Haematol. 41: 414-419.
  • PREVOT P.P., BESCHIN A., LINS L., BEAUFAYS J., GROSJEAN A., BRUYS L., ADAM B., BROSSARD M., BRASSEUR R., ZOUAOUI BOUDJELTIA K., VANHAMME L., GODFROID E. 2009: Exosites mediate the anti-inflammatory effects of a multifunctional serpin from the saliva of the tick Ixodes ricinus. FEBS J. 276: 3235-3246.
  • RAHMAN M.M., MCFADDEN G. 2006: Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog. 2: e4.
  • RAMACHANDRA R.N., WIKEL S.K. 1992: Modulation of host-immune responses by ticks (Acari: Ixodidae): effect of salivary gland extracts on host macrophages and lymphocyte cytokine production. J. Med. Entomol. 29: 818-826.
  • RIBEIRO J.M. 1987: Ixodes dammini: salivary anti-complement activity. Exp. Parasitol. 64: 347-353.
  • SEVERINOVA J., SALAT J., KROcOVA Z., REZNIcKOVA J., DEMOVA H., HORKA H., KOPECKy J. 2005: Co-inoculation of Borrelia afzelii with tick salivary gland extract influences distribution of immunocompetent cells in the skin and lymph nodes of mice. Folia Microbiol. 50: 457-463.
  • SINGH K., DAVIES G., ALENAZI Y., EATON J.R.O., KAWAMURA A., BHATTACHARYA S. 2017: Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities. Sci. Rep. 7: 4267.
  • STEEN N.A., BARKER S.C., ALEWOOD P.F. 2006: Proteins in the saliva of the Ixodida (ticks): pharmacological features and biological significance. Toxicon 47: 1-20.
  • STEERE A.C., COBURN J., GLICKSTEIN L. 2004: The emergence of Lyme disease. J. Clin. Invest. 113: 1093-1101.
  • SUN Y., XU R. 2003: Ability of Ixodes persulcatus, Haemaphysalis concinna and Dermacentor silvarum ticks to acquire and transstadially transmit Borrelia garinii. Exp. Appl. Acarol. 31: 151-160.
  • VACHIERY N., PUECH C., CAVELIER P., RODRIGUES V., APRELON R., LEFRANcOIS T., MARTINEZ D., EPARDAUD M. 2015: An in vitro model to assess the immunosuppressive effect of tick saliva on the mobilization of inflammatory monocyte-derived cells. Vet. Res. 46: 117.
  • VANcOVA I., HAJNICKA V. SLOVAK M., NUTTALL P.A. 2010: Anti-chemokine activities of ixodid ticks depend on tick species, developmental stage, and duration of feeding. Vet. Parasitol. 167: 274-278.
  • WIKEL S. 2013: Ticks and tick-borne pathogens at the cutaneous interface: host defences, tick countermeasures, and a suitable environment for pathogen establishment. Front. Microbiol. 4: 337.
  • ZEIDNER N., DREITZ M., BELASCO D., FISH D. 1996: Suppression of acute Ixodes scapularis -induced Borrelia burgdorferi infection using tumor necrosis factor-alpha, interleukin-2, and interferon-gamma. J. Infect. Dis. 173: 187-195.